Insights
We regularly publish articles for anyone interested in the latest developments in obesity, overweight, health and medicine. Whether you are a patient, healthcare provider or just interested, we are here to learn more and support.
Latest insight
Retatrutide is an experimental, once-weekly injectable medicine developed by Eli Lilly that is being studied for weight loss and metabolic conditions. The drug has attracted considerable attention because clinical studies have shown very large average weight reductions. However, it is important to emphasize that retatrutide is not (yet) routinely available and is still in clinical development.
Read more »
Our offer:
- •Your GLP-1 medication, from our own Aevita pharmacy in Soest, safely prescribed by Dutch doctors
- •(Refrigerated) home delivery, free and at a time that suits you
- •Intensive guidance from our dedicated team of coaches and nurses
- •Unlimited chat with your care team
- •(Video) consultations whenever you need them
- •Access to the Aevita Life App with check-ins, progress tracking, recipes, insights and more
This way you get everything you need to lose weight successfully and safely. Without extra costs for guidance or app functionalities.
Start your intake now >